An Unbiased View of conolidine
These benefits, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 help the concept of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Conditions.Importantly, these receptors have been identified